PepGen

Investors in PepGen Inc. have a potential opportunity to play a pivotal role in a securities fraud lawsuit against the biopharmaceutical company. Based in Portland, Maine, PepGen is focused on developing transformative therapies for patients with genetic diseases. Growing concerns over the company’s transparency regarding its business practices have led to heightened scrutiny from investors seeking accountability. The lawsuit concerns assertions that PepGen may have misled investors about its therapeutic pipeline and financial health. Stakeholders have gathered to discuss the implications of these claims, with potential leads emerging to steer the legal proceedings. Legal experts … Read more